Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Excuse my ignorance

Considering that there are 400 million shares issued and held by various holders, 5.1 million volume is anemic at its best. Obviously, there's another chapter to this saga and I await for it to unfold

Share
New Message
Please login to post a reply